SH

Shanghai Healthcare Capital

Asia, Shanghai, China, Huangpu

Description

Shanghai Healthcare Capital invests in healthcare ventures and focuses on innovative solutions and growth opportunities in the industry.

Investor Profile

Shanghai Healthcare Capital has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series D, Series A rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Pharmaceutical, Biotechnology, Life Science.

Stage Focus

  • Series B (33%)
  • Series D (33%)
  • Series A (33%)

Country Focus

  • China (67%)
  • United States (33%)

Industry Focus

  • Pharmaceutical
  • Biotechnology
  • Life Science
  • Health Care
  • Therapeutics
  • Cloud Computing
  • Dsp
  • Manufacturing
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shanghai Healthcare Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
HBM Partners
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
AC
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
IA
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Infinitum Partners
North America, Florida, United States, Miami
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Boyu Capital
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Shanghai Healthcare Capital?

VelaVigo

Shanghai, Shanghai, China

VelaVigo is a start-up company engaged in macromolecular biopharmaceutical.

BiopharmaBiotechnologyHealth CareTherapeutics
SeedJul 28, 2025
Amount Raised: $60,000,000
ArriVent Biopharma

Pennsylvania Furnace, Pennsylvania, United States

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

BiotechnologyLife SciencePharmaceutical
Series BDec 29, 2022
Amount Raised: $155,000,000
Abbisko Therapeutics

Shanghai, Shanghai, China

Abbisko Therapeutics is a drug company dedicated to innovative drug research and development.

Health CarePharmaceuticalTherapeutics
Series DJan 7, 2021
Amount Raised: $123,000,000
VeriSilicon Holdings

Shanghai, Shanghai, China

VeriSilicon Holdings is an IC design foundry that provides custom silicon solutions and system-on-chip turnkey services.

Cloud ComputingDSPManufacturingSemiconductor
Series ASep 3, 2018